Omontys Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Omontys: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PEGINESATIDE helps your body make more red blood cells. This medicine is used to treat anemia caused by chronic kidney disease.

In-Depth Information
Select a Medication

Omontys 20mg/2ml Solution for Injection

NDC: 647640620
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Anemia

Storage Information
Discard entered multi-dose vial after 28 days
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Store in carton until time of use
Omontys 20mg/2ml Solution for Injection

Reported Side Effects for Omontys 20mg/2ml Solution for Injection

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Antibody Formation Incidence:
1.2%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
10.7%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
10.9%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
12.2%*
Severity: MILD
Onset: EARLY
Infection Incidence:
12.4%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
13.2%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
14.2%*
Severity: MODERATE
Onset: RAPID
Vomiting Incidence:
15.3%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
15.3%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
15.4%*
Severity: MILD
Onset: EARLY
Cough Incidence:
15.9%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
17.4%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
18.4%*
Severity: MODERATE
Onset: EARLY
Loose Stools Incidence:
18.4%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Omontys

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5